Matt Kaeberlein

PhD, CEO at Optispan, Inc.

Speaker

Dr. Matt Kaeberlein is Chief Executive Officer of Optispan, Inc., Affiliate Professor at the University of Washington, and Co-Founder of both the Dog Aging Project and the Dog Aging Institute (501c3). He is internationally recognized for his work on the biological mechanisms of aging and their impact on healthspan and longevity, in both humans and companion animals.

Dr. Kaeberlein is a Fellow of the American Association for the Advancement of Science, the American Aging Association, and the Gerontological Society of America. He has published more than 250 scientific papers on the biology of aging and has received awards from leading organizations including the Gerontological Society of America, Ellison Medical Foundation, Alzheimer’s Association, American Federation for Aging Research, Glenn Foundation, Murdock Trust, and the National Institutes of Health.

In the private sector, Dr. Kaeberlein has co-founded two companies: Optispan, a healthcare technology company advancing healthspan medicine, and Ora Biomedical, a biotechnology company pioneering the use of robotics and artificial intelligence for large-scale longevity drug discovery. He has also served on Scientific Advisory Boards for numerous companies and venture funds, including resTORbio, Purina, Moonwalk Biosciences, Loyal, TriviumVet, Yuva Biosciences, PetLabCo, Healthspan Brazil S.A., and LongeVC.

At the University of Washington, Dr. Kaeberlein was founding Director of the Healthy Aging and Longevity Research Institute and of the Biological Mechanisms of Healthy Aging Training Program. He also served as Director of the Nathan Shock Center of Excellence in the Basic Biology of Aging, President and Chair of the American Aging Association, and as a member of the Board of Directors for the Federation of American Societies for Experimental Biology and the Alliance for Longevity Initiatives (A4Li).